Durogesic DTrans 50 micrograms/hour Transdermal Patch
Authorisation PA22612/004/002 · Janssen Sciences Ireland Unlimited Company
- Licence holder
- Janssen Sciences Ireland Unlimited Company (all products →)
- Active substance
- Fentanyl
- Clinical trials
- 31 clinical trials →
- Dosage form
- Transdermal patch
- Route of administration
- Transdermal use
- ATC codes
- N02AB, N02AB03
- First authorised
- 31/10/1995
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Fentanyl: supply and approvals
51 authorised products on the HPRA list contain Fentanyl. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 17 Nov 2026)
- US shortage (FDA)
- Fentanyl Citrate Injection: in shortage, updated 9 Nov 2026
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 17 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 31 years (since 31 October 1995). The HPRA list marks it as marketed in Ireland.
Other medicines with Fentanyl in Ireland
34 other products on the HPRA list contain Fentanyl, from 8 licence holders; 28 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Abstral 100 microgram sublingual tablets | Grunenthal Pharma Limited. | National authorisation (PA) | Marketed |
| Abstral 200 microgram sublingual tablets | Grunenthal Pharma Limited. | National authorisation (PA) | Marketed |
| Abstral 300 microgram sublingual tablets | Grunenthal Pharma Limited. | National authorisation (PA) | Marketed |
| Abstral 400 microgram sublingual tablets | Grunenthal Pharma Limited. | National authorisation (PA) | Marketed |
| Abstral 600 microgram sublingual tablets | Grunenthal Pharma Limited. | National authorisation (PA) | Marketed |
| Abstral 800 microgram sublingual tablets | Grunenthal Pharma Limited. | National authorisation (PA) | Marketed |
| Actiq 200 micrograms compressed lozenge with integral oromucosal applicator | Phoenix Labs Unlimited Company | National authorisation (PA) | Marketed |
| Actiq 400 micrograms compressed lozenge with integral oromucosal applicator | Phoenix Labs Unlimited Company | National authorisation (PA) | Marketed |
| Actiq 600 micrograms compressed lozenge with integral oromucosal applicator | Phoenix Labs Unlimited Company | National authorisation (PA) | Marketed |
| Durogesic DTrans 100 micrograms/hour transdermal patch | Janssen Sciences Ireland Unlimited Company | National authorisation (PA) | Marketed |
| Durogesic DTrans 12 micrograms/hour Transdermal Patch | Janssen Sciences Ireland Unlimited Company | National authorisation (PA) | Marketed |
| Durogesic DTrans 25 micrograms/hour transdermal patch | Janssen Sciences Ireland Unlimited Company | National authorisation (PA) | Marketed |
Other substances in ATC group N02AB
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 3 other active substances share the group N02AB with this product:
FENTANYL CITRATE (11) · Fentanyl, as citrate salt (2) · Pethidine hydrochloride (1)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Janssen Sciences Ireland Unlimited Company holds 27 products on the HPRA list, with 6 different active substances; 25 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 18 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.